NumerixS Investment Technologies’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,443
| Closed | -$65K | – | 1192 |
|
|
2020
Q1 | $65K | Buy |
+1,443
| New | +$65K | 0.03% | 552 |
|
|
2019
Q3 | – | Sell |
-962
| Closed | -$68K | – | 1137 |
|
|
2019
Q2 | $68K | Buy |
+962
| New | +$68K | 0.02% | 703 |
|
|
2019
Q1 | – | Sell |
-641
| Closed | -$54K | – | 1235 |
|
|
2018
Q4 | $54K | Sell |
641
-1,122
| -64% | -$94.5K | 0.02% | 743 |
|
|
2018
Q3 | $301K | Sell |
1,763
-1,443
| -45% | -$246K | 0.06% | 445 |
|
|
2018
Q2 | $416K | Sell |
3,206
-1,122
| -26% | -$146K | 0.09% | 300 |
|
|
2018
Q1 | $437K | Buy |
4,328
+3,206
| +286% | +$324K | 0.11% | 210 |
|
|
2017
Q4 | $96K | Sell |
1,122
-4,168
| -79% | -$357K | 0.02% | 705 |
|
|
2017
Q3 | $449K | Sell |
5,290
-1,763
| -25% | -$150K | 0.1% | 260 |
|
|
2017
Q2 | $534K | Sell |
7,053
-3,527
| -33% | -$267K | 0.08% | 311 |
|
|
2017
Q1 | $699K | Sell |
10,580
-801
| -7% | -$52.9K | 0.08% | 305 |
|
|
2016
Q4 | $721K | Buy |
11,381
+2,885
| +34% | +$183K | 0.09% | 290 |
|
|
2016
Q3 | $541K | Buy |
8,496
+3,206
| +61% | +$204K | 0.07% | 359 |
|
|
2016
Q2 | $394K | Buy |
+5,290
| New | +$394K | 0.05% | 487 |
|